Poniard Pharmaceuticals, Inc. Announces Participation in Biotechnology Industry Organization (BIO) InvestorForum 2007

SOUTH SAN FRANCISCO, Calif., Oct. 1 /PRNewswire-FirstCall/ -- Poniard Pharmaceuticals, Inc. (Nasdaq: PARD - News), a biopharmaceutical company focused on oncology, today announced that Jerry McMahon, Ph.D., chairman and CEO, will present at the 4th Annual BIO InvestorForum on Wednesday, October 10, at 3:15 p.m. Pacific Time at the Palace Hotel in San Francisco.

MORE ON THIS TOPIC